{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:39:08Z","timestamp":1777959548372,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS Grants-in-Aids for Scientific Research","award":["20K10491"],"award-info":[{"award-number":["20K10491"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Screening for latent tuberculosis infection (LTBI) among migrant population has become a critical issue for many low tuberculosis (TB) burden countries. Evidence regarding effectiveness of LTBI programs are limited, however, partly because of paucity of national data on treatment outcomes for LTBI. In Japan, notification of LTBI is mandatory, and its treatment outcome is reported as part of Japan\u2019s national TB surveillance system. We thus conducted a detailed analysis of LTBI among foreign-born persons, to update the epidemiological trend of newly notified LTBI between 2007 and 2018, and to examine the treatment regimen and outcome of those notified in 2016 and 2017, focusing specifically on the potential risk factors for lost to follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We extracted and analyzed the data of newly notified LTBI patients from the Japan Tuberculosis Surveillance System to examine the overall trend of notification and by age groups and modes of detection between 2007 and 2018, and the cohort data for treatment regimen and outcomes of foreign-born persons notified with LTBI in 2016 and 2017. Trends and proportions were summarized descriptively, and logistic regression analysis was conducted to identify potential risk factors for lost to follow-up. Comparisons were made with the Japan-born patients where appropriate, using chi-squared tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both the number and proportion of LTBI among foreign-born persons have been constantly increasing, reaching 963 cases in 2018. Cohort analysis of the surveillance data indicated that the proportion of those on shorter regimen was higher among the foreign- than Japan-born patients (5.5% vs. 1.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The proportion of those who have been lost to follow-up and transferred outside of Japan combined was higher among the foreign- than Japan-born patients (12.0% vs, 8.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Risk factors for lost to follow-up were being employed on a temporal basis, and job status unknown (adjusted odds ratios 3.11 and 4.09, 95% confidence intervals 1.34\u20137.26 and 1.60\u201310.48, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Migrant population face greater risk of interrupting LTBI treatment, and interventions to improve adherence are a critical component of programmatic management of LTBI. Further studies are needed to explore the cultural and socioeconomic situation in which foreign-born persons undergo LTBI treatment in Japan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05712-1","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T05:06:49Z","timestamp":1610168809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-844X","authenticated-orcid":false,"given":"Lisa","family":"Kawatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Uchimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ohkado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"5712_CR1","unstructured":"European Centre for Disease Prevention and Control (ECDC)\/World Health Organization Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2018\u20132016 data. Stockholm: ECDC; 2018. Available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/ecdc-tuberculosis-surveillance-monitoring-Europe-2018-19mar2018.pdf WHO. Accessed 3 Apr 2020."},{"key":"5712_CR2","volume-title":"Reported Tuberculosis in the United States, 2017","author":"Centers for Disease Control and Prevention (CDC)","year":"2018","unstructured":"Centers for Disease Control and Prevention (CDC). Reported Tuberculosis in the United States, 2017. Atlanta, GA: US Department of health and human services, CDC; 2018."},{"key":"5712_CR3","first-page":"3","volume":"41","author":"C Toms","year":"2017","unstructured":"Toms C, Stapledon R, Coulter C, Douglas P. The National Tuberculosis Advisory Committee. Tuberculosis notifications in Australia, 2014. Commun Dis Intell. 2017;41:3.","journal-title":"Commun Dis Intell"},{"key":"5712_CR4","volume-title":"Tuberculosis in Japan \u2013 annual report 2019","author":"Tuberculosis Surveillance Center","year":"2019","unstructured":"Tuberculosis Surveillance Center. Tuberculosis in Japan \u2013 annual report 2019. Tokyo: Department of Epidemiology and Clinical Research, the Research Institute of Tuberculosis; 2019."},{"issue":"9","key":"5712_CR5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3201\/eid1809.120128","volume":"18","author":"M Pareek","year":"2012","unstructured":"Pareek M, Baussano I, Abubakar I, Dye C, Lalvani A. Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis. 2012;18(9):1422\u20139. https:\/\/doi.org\/10.3201\/eid1809.120128.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"5712_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40291-015-0135-6","volume":"19","author":"JR Campbell","year":"2015","unstructured":"Campbell JR, Chen W, Johnston J, Cook V, Elwood K, Krot J, Marra F. Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis. Mol Diagn Ther. 2015;19(2):107\u201317. https:\/\/doi.org\/10.1007\/s40291-015-0135-6.","journal-title":"Mol Diagn Ther"},{"key":"5712_CR7","volume-title":"updated and consolidated guidelines for programmatic management","author":"Latent tuberculosis infection","year":"2018","unstructured":"Latent tuberculosis infection. updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018. License: CC BY-NC-SA 3.0 IGO."},{"key":"5712_CR8","first-page":"497","volume":"88","author":"The Prevention Committee and the Treatment Committee of the Japanese Society for Tuberculosis","year":"2013","unstructured":"The Prevention Committee and the Treatment Committee of the Japanese Society for Tuberculosis. Treatment Guideline on LTBI. Kekkaku. 2013;88:497\u2013512.","journal-title":"Kekkaku"},{"key":"5712_CR9","volume-title":"Annual Report on Statistics on Legal Migrants","author":"Ministry of Justice","year":"2019","unstructured":"Ministry of Justice. Annual Report on Statistics on Legal Migrants, 2019. http:\/\/www.moj.go.jp\/housei\/toukei\/toukei_ichiran_nyukan.html."},{"key":"5712_CR10","first-page":"431","volume":"92","author":"Y Murase","year":"2017","unstructured":"Murase Y, Ohkado A, Watanabe Y, Kaguraoka S, Ishihara K, Homareda C, Uchimura K, Maeda S, Takii T, Ishikawa N. Transmission dynamics of mycobacterium tuberculosis between foreign-nationals and Japanese tuberculosis patients living in Shinjuku-City, Tokyo. Japan Kekkaku. 2017;92:431\u20139.","journal-title":"Japan Kekkaku"},{"issue":"11","key":"5712_CR11","doi-asserted-by":"publisher","first-page":"e0186588","DOI":"10.1371\/journal.pone.0186588","volume":"12","author":"L Kawatsu","year":"2017","unstructured":"Kawatsu L, Uchimura K, Ohkado A. Trend and treatment status of latent tuberculosis infection patients in Japan - analysis of Japan TB surveillance data. PLoS One. 2017;12(11):e0186588. https:\/\/doi.org\/10.1371\/journal.pone.0186588.","journal-title":"PLoS One"},{"issue":"1","key":"5712_CR12","first-page":"462","volume":"55","author":"Y Tanaka","year":"2018","unstructured":"Tanaka Y, Suzuki M. Gaikokujin ryugakusei no senzaisei kekkaku kansenshou ni taisuru IGRA to kyoubu X sen niyoru kenko kanri (Medical examination via IGRA and chest X-ray for foreign-born students). Campus Health. 2018;55(1):462\u20134 In Japanese.","journal-title":"Campus Health"},{"issue":"1","key":"5712_CR13","first-page":"35","volume":"37","author":"T Nishimura","year":"2019","unstructured":"Nishimura T, Mori M. Gaikokujin ryugakusei no kekkaku kansen chousa (screening for TB infection among foreign-born students). Bull Keio University Health Center. 2019;37(1):35\u20139 In Japanese.","journal-title":"Bull Keio University Health Center"},{"issue":"6","key":"5712_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","volume":"46","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Abubaker I, Abdel Aziz M, Baddeley A, Barreira D, et al. Management of latent mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. European Respir J. 2015;46(6):1563\u201376. https:\/\/doi.org\/10.1183\/13993003.01245-2015.","journal-title":"European Respir J"},{"issue":"11","key":"5712_CR15","first-page":"1235","volume":"12","author":"Y Hirsch-Moverman","year":"2008","unstructured":"Hirsch-Moverman Y, Daftary A, Franks J, Colson P. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis. 2008;12(11):1235\u201354.","journal-title":"Int J Tuberc Lung Dis."},{"key":"5712_CR16","doi-asserted-by":"publisher","unstructured":"Sandgren A, Noordegraaf-Shouten MV, van Kessel F, Stuuman A, Oordt-Speets A and van der Werf MS. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infect Dis. 2016; 16:204. DOI: https:\/\/doi.org\/10.1186\/s12879-016-1550y.","DOI":"10.1186\/s12879-016-1550y"},{"issue":"11","key":"5712_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","volume":"16","author":"H Alsdurf","year":"2016","unstructured":"Alsdurf H, Hill PC, Metteelli A, Getahun H, Menzies D. The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(11):1269\u201378. https:\/\/doi.org\/10.1016\/S1473-3099(16)30216-X.","journal-title":"Lancet Infect Dis"},{"key":"5712_CR18","first-page":"775","volume":"10","author":"AM Nyamathi","year":"2006","unstructured":"Nyamathi AM, Christiani A, Nahid P, Gregerson P, Leake B. A randomized controlled trial of two treatment program for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis. 2006;10:775\u201382.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5712_CR19","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1378\/chest.130.6.1712","volume":"130","author":"A Lardizabal","year":"2006","unstructured":"Lardizabal A, Passannante M, Kojakali F, Hayden C, Reichman LB. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin. Chest. 2006;130:1715\u20137.","journal-title":"Chest."},{"key":"5712_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12889-020-8390-9","volume":"20","author":"I Spruijt","year":"2020","unstructured":"Spruijt I, Haile DT, Erkens C, van den Hof S, Goosen S, ten Kate A, Tshome H, Karels M, Koenders M, Suurmond J. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans. BMC Public Health. 2020;20:315. https:\/\/doi.org\/10.1186\/s12889-020-8390-9.","journal-title":"BMC Public Health"},{"key":"5712_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","volume":"174","author":"FK Shieh","year":"2006","unstructured":"Shieh FK, Snyder G, Horsburgh CR, Bernado J, Murphy C, Saukkonen JJ. Predicting non-completion of treatment for latent Tuberculous infection. A prospective survey. Am J Respir Crit Care Med. 2006;174:717\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"5712_CR22","first-page":"805","volume":"62","author":"Center for Disease Control and Prevention","year":"2013","unstructured":"Center for Disease Control and Prevention. Transmission of mycobacterium tuberculosis in a high-school and school-based supervision of an isoniazid-rifapentine regimen for preventing tuberculosis - Colorado, 2011-2012. MMWR Morb Mortal Wkly Rep. 2013;62:805\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5712_CR23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1183\/09031936.00009114","volume":"44","author":"R Sloot","year":"2014","unstructured":"Sloot R, van der Loeff MF S, Kouw PM, Borgdorff MW. Yield of tuberculosis contact investigation in Amsterdam: opportunities for improvement. Eur Respir J. 2014;44:714\u201324.","journal-title":"Eur Respir J"},{"key":"5712_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/00007611-200295040-00009","volume":"95","author":"MR Reichler","year":"2002","unstructured":"Reichler MR, Reves R, Bur S, Ford J, Thompson V, Mangura B. Treatment of latent tuberculosis infection in contacts in new tuberculosis cases in the United States. South Med J. 2002;95:414\u201320.","journal-title":"South Med J"},{"key":"5712_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.amepre.2005.06.014","volume":"29","author":"MC White","year":"2005","unstructured":"White MC, Tulsky JP, Menedez E, Goldenson J, Kawamura LM. Incidence of TB in inmates with latent TB infection: 5 year follow-up. Am J Prev Med. 2005;29:295\u2013301.","journal-title":"Am J Prev Med"},{"key":"5712_CR26","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.2105\/AJPH.93.10.1637","volume":"93","author":"DY Kim","year":"2003","unstructured":"Kim DY, Rizdon R, Giles B, Mireles T, Garrity K, Hatchcock AL, Crowder D, Jackson R, Taylor Z. A no-name tuberculosis tracking system. Am J Public Health. 2003;93:1637\u20139.","journal-title":"Am J Public Health"},{"key":"5712_CR27","first-page":"76","volume":"8","author":"SV Goldberg","year":"2004","unstructured":"Goldberg SV, Wallace J, Jackson JC, Cahulk CP, Nolan CM. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis. 2004;8:76\u201382.","journal-title":"Int J Tuberc Lung Dis."},{"key":"5712_CR28","first-page":"563","volume":"93","author":"E Shigeto","year":"2018","unstructured":"Shigeto E. Nihon no kekkakuchiryou niokeru shomondai (issues in treatment of tuberculosis in Japan). Kekkaku. 2018;93:563\u20138 In Japanese.","journal-title":"Kekkaku."},{"key":"5712_CR29","first-page":"41","volume":"95","author":"Y Nagata","year":"2020","unstructured":"Nagata Y, Takayanagi K, Yano R, Sawada T, Morita N, Murakami K, Takasaki J. Utilization of medical interpreters for tuberculosis patients in Japan: a questionnaire survey. Kekkaku. 2020;95:41\u20136.","journal-title":"Kekkaku."},{"key":"5712_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1525-1446.1998.tb00316.x","volume":"15","author":"RL Ailinger","year":"1998","unstructured":"Ailinger RL, Dear MR. Adherence to tuberculosis preventive therapy among Latino immigrants. Public Health Nurs. 1998;15:19\u201324.","journal-title":"Public Health Nurs"},{"key":"5712_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","volume":"168","author":"A LoBue","year":"2003","unstructured":"LoBue A, Moser S. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med. 2003;168:443\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"5712_CR32","first-page":"1296","volume":"127","author":"N Lobato","year":"2005","unstructured":"Lobato N, Reves R, Jasmar M, Grabau C, Bock N, Shang N, et al. Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons. Chest. 2005;127:1296\u2013303.","journal-title":"Chest."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05712-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T05:11:24Z","timestamp":1610169084000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05712-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5712"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05712-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-44087\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-44087\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-44087\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-44087\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance obtained from the Institution al Review Board of the Research Institute of Tuberculosis (reference number RIT\/IRB 2020\u201308). Informed consent as deemed unnecessary as the JTBS data does not include case identifiers, as according to the Ethical Guidelines for Epidemiological Research established by Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare of Japan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}